Boswellia serrata Extract and Its Bioactive Compound 3-O-Acetyl-11-Keto-β-Boswellic Acid (AKBA) Induce ROS-Mediated Intracellular Clearance of Porphyromonas gingivalis in Human Gingival Epithelial Cells
Authors:
- David VangDVDavid Vang
- Pedro Henrique CarneiroPCPedro Henrique Carneiro
- Laura HenaoLHLaura Henao
- Adrien StroumzaASAdrien Stroumza
- Harmony Matshik DakafayHDHarmony Matshik Dakafay
- Scott DavisSDScott Davis
- David M. OjciusDODavid M. Ojcius
- Cassio Luiz Coutinho Almeida-Da-SilvaCassio Luiz Coutinho Almeida-Da-Silva
- Aline Cristina Abreu Moreira-SouzaAMAline Cristina Abreu Moreira-Souza
Open Access
- 11 February 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (4) , 1733
Abstract
Porphyromonas gingivalis is a keystone pathogen in periodontitis, known for its ability to invade gingival epithelial cells and persist intracellularly. Conventional antimicrobials are often ineffective against intracellular pathogens, and natural products remain poorly explored in this context. Here, we investigated the antimicrobial effects of Boswellia serrata extract and its bioactive compounds on the dynamics of P. gingivalis infection in human gingival epithelial cells. During early times of infection, B. serrata extracts stimulated phagocytosis and increased bacterial internalization, suggesting modulation of epithelial uptake mechanisms. At later times of infection, B. serrata increased production of reactive oxygen species (ROS) in host cells and markedly reduced intracellular bacterial load. The antimicrobial effect was abolished by the ROS scavenger N-acetylcysteine, confirming a role for oxidative mechanisms in the clearance of P. gingivalis. Similar results were obtained with 3-O-acetyl-11-keto-β-boswellic acid (AKBA), one of the major boswellic acid derivatives found in B. serrata extract. These findings reveal a dual role of B. serrata compounds in response to P. gingivalis infection, in which B. serrata initially facilitates bacterial entry and subsequently promotes ROS-dependent intracellula These findings provide new mechanistic insights into the regulation of host–pathogen interactions by the natural products found in B. serrata. Our results support the therapeutic potential of B. serrata-derived compounds for managing periodontal infections.Keywords
All Related Versions
Funding Information
- University of the Pacific, Arthur A. Dugoni, School of Dentistry (D30060)
- University of the Pacific, Arthur A. Dugoni, School of Dentistry (C10219)
This publication has 43 references indexed in Scilit:
- Acetyl-11-keto-beta-boswellic acid inhibits cell proliferation and growth of oral squamous cell carcinoma via RAB7B-mediated autophagyToxicology and Applied Pharmacology, 2024
- Synthesis of 3-O-Acetyl-11-keto-β-boswellic Acid (AKBA)-Derived Amides and Their Mitochondria-Targeted Antitumor ActivitiesACS Omega, 2022
- Acetyl-11-keto-β-boswellic acid (AKBA) Attenuates Oxidative Stress, Inflammation, Complement Activation and Cell Death in Brain Endothelial Cells Following OGD/ReperfusionNeuroMolecular Medicine, 2019
- A pilot, randomized, double‐blind, placebo‐controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the kneePhytotherapy Research, 2019
- Association between periodontal pathogens and systemic diseaseBiomedical Journal, 2019
- P2X7 receptor-mediated leukocyte recruitment and Porphyromonas gingivalis clearance requires IL-1β production and autocrine IL-1 receptor activationImmunobiology, 2019
- Is the inflammasome relevant for epithelial cell function?Microbes and Infection, 2016
- Polyphenols as antimicrobial agentsCurrent Opinion in Biotechnology, 2012
- Epithelium: At the interface of innate and adaptive immune responsesJournal of Allergy and Clinical Immunology, 2007
- Acetyl-11-keto-β-boswellic acid, a constituent of a herbal medicine from Boswellia serrata resin, attenuates experimental ileitisInternational Journal of Colorectal Disease, 2001